Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion type Assertion NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_head.
- NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion description "[After multivariate analyses the independent positive predictors for SVR after treatment for chronic hepatitis C with Peg-IFN and RBV were: absence of an AIDS-defining illness (p=0.001), HCV viral load lower than 600,000IU/mL at the onset of treatment (p=0.003), higher liver enzyme levels (p=0.039) at baseline, infection with genotypes 2 or 3 (p=0.003), and no transient treatment interruption (p=0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_provenance.
- NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion evidence source_evidence_literature NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_provenance.
- NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion SIO_000772 25181403 NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_provenance.
- NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion wasDerivedFrom befree-2016 NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_provenance.
- NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_assertion wasGeneratedBy ECO_0000203 NP1216189.RA47N2zQlwWqtQ-tuEIbfsKAVQPqWrID1cu0SZ7L4EKrY130_provenance.